Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$967K Sell
7,473
-433
-5% -$50.7K 0.76% 39
2026
Q1
$958K Sell
7,906
-369
-4% -$42.6K 0.82% 37
2025
Q4
$878K Buy
+8,275
New +$777K 0.76% 37
2023
Q2
Sell
-11,886
Closed -$1.27M 50
2023
Q1
$1.27M Hold
11,886
2.51% 16
2022
Q4
$1.33M Buy
11,886
+1,158
+11% +$118K 2.96% 13
2022
Q3
$924K Buy
+10,728
New +$958K 2.36% 15

Other funds holding MRK

Virtus Family Office's MRK Position: Q2 2026 in Review

Virtus Family Office reduced its Merck (MRK) stake by 5.5% in Q2 2026, selling an estimated $50.7K and leaving 7,473 shares worth $967K. The position accounts for 0.76% of the portfolio, ranked #39.

Virtus Family Office first reported a position in MRK in Q3 2022 and has held it in 6 quarters since. The position peaked at $1.33M in Q4 2022. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Virtus Family Office held 7,473 shares of Merck worth $967K as of Q2 2026.
  • Virtus Family Office sold 433 Merck shares in Q2 2026, an estimated $50.7K.
  • Merck made up 0.76% of Virtus Family Office's portfolio in Q2 2026, its #39 holding.
  • Virtus Family Office first reported a position in Merck in Q3 2022 and has held it in 6 quarters since.
  • Virtus Family Office's Merck position peaked at $1.33M in Q4 2022.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Virtus Family Office's 13F filing for Q2 2026, filed 4 Aug 2026.